BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20211160)

  • 1. Matrix metalloproteinase (MMP)-9 genotypes and haplotypes in preeclampsia and gestational hypertension.
    Palei AC; Sandrim VC; Duarte G; Cavalli RC; Gerlach RF; Tanus-Santos JE
    Clin Chim Acta; 2010 Jun; 411(11-12):874-7. PubMed ID: 20211160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.
    Palei AC; Sandrim VC; Amaral LM; Machado JS; Cavalli RC; Lacchini R; Duarte G; Tanus-Santos JE
    Pharmacogenomics J; 2012 Dec; 12(6):489-98. PubMed ID: 21769110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy.
    Palei AC; Sandrim VC; Amaral LM; Machado JS; Cavalli RC; Duarte G; Tanus-Santos JE
    Exp Mol Pathol; 2012 Apr; 92(2):217-21. PubMed ID: 22327101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy.
    Palei AC; Sandrim VC; Amaral LM; Machado JS; Cavalli RC; Lacchini R; Duarte G; Tanus-Santos JE
    Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):262-7. PubMed ID: 22672240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of trophoblast invasion related genes mRNA and protein in human placenta in preeclampsia].
    Zhang H; Lin QD; Qiao C
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):509-13. PubMed ID: 17083831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension.
    Sandrim VC; Palei AC; Luizon MR; Izidoro-Toledo TC; Cavalli RC; Tanus-Santos JE
    Pharmacogenomics J; 2010 Feb; 10(1):40-5. PubMed ID: 19704415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension.
    Sandrim VC; Palei AC; Cavalli RC; Araújo FM; Ramos ES; Duarte G; Tanus-Santos JE
    Mol Hum Reprod; 2009 Feb; 15(2):115-20. PubMed ID: 19060000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension.
    Palei AC; Sandrim VC; Cavalli RC; Tanus-Santos JE
    Clin Biochem; 2008 Jul; 41(10-11):875-80. PubMed ID: 18477480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. eNOS haplotypes associated with gestational hypertension or preeclampsia.
    Sandrim VC; Palei AC; Cavalli RC; Araújo FM; Ramos ES; Duarte G; Tanus-Santos JE
    Pharmacogenomics; 2008 Oct; 9(10):1467-73. PubMed ID: 18855535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-4 -590 (C>T), toll-like receptor-2 +2258 (G>A) and matrix metalloproteinase-9 -1562 (C>T) polymorphisms in pre-eclampsia.
    Fraser R; Walker JJ; Ekbote UV; Martin KL; McShane P; Orsi NM
    BJOG; 2008 Jul; 115(8):1052-6; discussion 1056. PubMed ID: 18651887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone synthase gene polymorphism is not associated with gestational hypertension or preeclampsia.
    de Vasconcelos D; Izidoro-Toledo TC; Sandrim VC; Tanus-Santos JE; Palei AC; Cavalli RC
    Clin Chim Acta; 2009 Feb; 400(1-2):139-41. PubMed ID: 19026620
    [No Abstract]   [Full Text] [Related]  

  • 12. Maternal iNOS genetic polymorphisms and hypertensive disorders of pregnancy.
    Amaral LM; Palei AC; Sandrim VC; Luizon MR; Cavalli RC; Duarte G; Tanus-Santos JE
    J Hum Hypertens; 2012 Sep; 26(9):547-52. PubMed ID: 21716319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the MMP-9 (C-1562 T) and TIMP-2 (G-418C) gene promoter polymorphisms in patients with chronic periodontitis.
    de Souza AP; Trevilatto PC; Scarel-Caminaga RM; de Brito RB; Barros SP; Line SR
    J Clin Periodontol; 2005 Feb; 32(2):207-11. PubMed ID: 15691353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease.
    Okamoto K; Mimura K; Murawaki Y; Yuasa I
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1102-8. PubMed ID: 15955221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
    Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
    Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase-1 and -9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population.
    Takemura N; Yoshida S; Kennedy S; Deguchi M; Ohara N; Maruo T
    J Soc Gynecol Investig; 2006 Apr; 13(3):232-6. PubMed ID: 16638593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional matrix metalloproteinase (MMP)-9 polymorphism modifies plasma MMP-9 levels in subjects environmentally exposed to mercury.
    Jacob-Ferreira AL; Passos CJ; Gerlach RF; Barbosa F; Tanus-Santos JE
    Sci Total Environ; 2010 Sep; 408(19):4085-92. PubMed ID: 20554312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epistasis among eNOS, MMP-9 and VEGF maternal genotypes in hypertensive disorders of pregnancy.
    Luizon MR; Sandrim VC; Palei AC; Lacchini R; Cavalli RC; Duarte G; Tanus-Santos JE
    Hypertens Res; 2012 Sep; 35(9):917-21. PubMed ID: 22573202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
    Rollin J; Régina S; Vourc'h P; Iochmann S; Bléchet C; Reverdiau P; Gruel Y
    Lung Cancer; 2007 May; 56(2):273-80. PubMed ID: 17208328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
    Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT
    J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.